108 related articles for article (PubMed ID: 32132043)
21. Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia.
Blaha M; Cermanova M; Blaha V; Jarolim P; Andrys C; Blazek M; Maly J; Smolej L; Zajic J; Masin V; Zimova R; Rehacek V
Atherosclerosis; 2008 Mar; 197(1):264-70. PubMed ID: 17540382
[TBL] [Abstract][Full Text] [Related]
22. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.
Tosoian JJ; Chappidi M; Feng Z; Humphreys EB; Han M; Pavlovich CP; Epstein JI; Partin AW; Trock BJ
BJU Int; 2017 May; 119(5):676-683. PubMed ID: 27367645
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml.
Ito K; Yokomizo A; Tokunaga S; Arai G; Sugimoto M; Akakura K; Hasumi H; Sakai H; Ouraji A; Oki R; Kashiwagi E; Kobori Y; Hirama H; Kitoh H; Uemura H; Hakariya T; Suzuki K;
J Urol; 2020 Jan; 203(1):83-91. PubMed ID: 31430244
[TBL] [Abstract][Full Text] [Related]
24. Circulating microRNAs in plasma among men with low-grade and high-grade prostate cancer at prostate biopsy.
McDonald AC; Vira M; Walter V; Shen J; Raman JD; Sanda MG; Patil D; Taioli E
Prostate; 2019 Jun; 79(9):961-968. PubMed ID: 30958910
[TBL] [Abstract][Full Text] [Related]
25. Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel.
Kim EH; Andriole GL; Crawford ED; Sjoberg DD; Assel M; Vickers AJ; Lilja H
J Urol; 2017 Apr; 197(4):1041-1047. PubMed ID: 27810449
[TBL] [Abstract][Full Text] [Related]
26. Loss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate Cancer.
Bruce HM; Stricker PD; Gupta R; Savdie RR; Haynes AM; Mahon KL; Lin HM; Kench JG; Horvath LG
Prostate; 2016 Dec; 76(16):1491-1500. PubMed ID: 27473574
[TBL] [Abstract][Full Text] [Related]
27. Testosterone Levels Correlate With Grade Group 5 Prostate Cancer: Another Step Toward Personalized Medicine.
Capogrosso P; Ventimiglia E; Moschini M; Boeri L; Farina E; Finocchio N; Gandaglia G; Fossati N; Briganti A; Montorsi F; Salonia A
Prostate; 2017 Feb; 77(2):234-241. PubMed ID: 27775173
[TBL] [Abstract][Full Text] [Related]
28. Validation of a 2-gene mRNA urine test for the detection of ≥GG2 prostate cancer in an opportunistic screening population.
Rubio-Briones J; Borque-Fernando A; Esteban LM; Mascarós JM; Ramírez-Backhaus M; Casanova J; Collado A; Mir C; Gómez-Ferrer A; Wong A; Aragón F; Calatrava A; López-Guerrero JA; Groskopf J; Schalken J; Van Criekinge W; Domínguez-Escrig J
Prostate; 2020 May; 80(6):500-507. PubMed ID: 32077525
[TBL] [Abstract][Full Text] [Related]
29. Metabolic syndrome increases the risk of aggressive prostate cancer detection.
Morote J; Ropero J; Planas J; Bastarós JM; Delgado G; Placer J; Celma A; de Torres IM; Carles J; Reventós J; Doll A
BJU Int; 2013 Jun; 111(7):1031-6. PubMed ID: 22883053
[TBL] [Abstract][Full Text] [Related]
30. Serum Vitamin D is Not Helpful for Predicting Prostate Cancer Aggressiveness Compared with the Prostate Health Index.
Stephan C; Lein M; Matalon J; Kilic E; Zhao Z; Busch J; Jung K
J Urol; 2016 Sep; 196(3):709-14. PubMed ID: 26976204
[TBL] [Abstract][Full Text] [Related]
31. Early-Life Alcohol Intake and High-Grade Prostate Cancer: Results from an Equal-Access, Racially Diverse Biopsy Cohort.
Michael J; Howard LE; Markt SC; De Hoedt A; Bailey C; Mucci LA; Freedland SJ; Allott EH
Cancer Prev Res (Phila); 2018 Oct; 11(10):621-628. PubMed ID: 30139875
[TBL] [Abstract][Full Text] [Related]
32. Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance.
Josefsson A; Wikström P; Egevad L; Granfors T; Karlberg L; Stattin P; Bergh A
Scand J Urol Nephrol; 2012 Aug; 46(4):247-57. PubMed ID: 22452635
[TBL] [Abstract][Full Text] [Related]
33. Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy.
Viers BR; Sukov WR; Gettman MT; Rangel LJ; Bergstralh EJ; Frank I; Tollefson MK; Thompson RH; Boorjian SA; Karnes RJ
Eur Urol; 2014 Dec; 66(6):1116-24. PubMed ID: 25052213
[TBL] [Abstract][Full Text] [Related]
34. The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance.
Kato M; Hirakawa A; Kobayashi Y; Yamamoto A; Ishida R; Sano T; Kimura T; Majima T; Ishida S; Funahashi Y; Sassa N; Fujita T; Matsukawa Y; Yamamoto T; Hattori R; Gotoh M; Tsuzuki T
Prostate; 2019 Jul; 79(10):1065-1070. PubMed ID: 31025722
[TBL] [Abstract][Full Text] [Related]
35. Biopsy Detected Gleason Pattern 5 is Associated with Recurrence, Metastasis and Mortality in a Cohort of Men with High Risk Prostate Cancer.
Stroup SP; Moreira DM; Chen Z; Howard L; Berger JH; Terris MK; Aronson WJ; Cooperberg MR; Amling CL; Kane CJ; Freedland SJ
J Urol; 2017 Dec; 198(6):1309-1315. PubMed ID: 28709888
[TBL] [Abstract][Full Text] [Related]
36. Association of elevated interleukin-33 serum levels with tumorstages in patients with prostate cancer.
Chatrabnous N; Jafarzadeh A; Ghaderi A; Ariafar A; Aminizadeh N; Ghassabi F; Nemati M
Eur Cytokine Netw; 2019 Dec; 30(4):144-150. PubMed ID: 32096476
[TBL] [Abstract][Full Text] [Related]
37. Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy.
Svatek RS; Karam JA; Roehrborn CG; Karakiewicz PI; Slawin KM; Shariat SF
Clin Cancer Res; 2008 Jun; 14(11):3362-6. PubMed ID: 18519764
[TBL] [Abstract][Full Text] [Related]
38. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G
BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328
[TBL] [Abstract][Full Text] [Related]
39. Interplay between exercise and BMI; results from an equal access, racially diverse biopsy study.
Michael J; Oyekunle T; Howard L; De Hoedt A; Hoyo C; Grant D; Freedland S
Cancer Causes Control; 2019 Jan; 30(1):13-20. PubMed ID: 30523509
[TBL] [Abstract][Full Text] [Related]
40. The association between sexual function and prostate cancer risk in US veterans.
Zapata DF; Howard LE; Frank J; Simon RM; Hoyo C; Grant DJ; Freedland SJ; Vidal AC
Asian J Androl; 2017; 19(2):191-195. PubMed ID: 27586025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
